company background image
CL logo

Colgate-Palmolive NYSE:CL Rapport sur les actions

Dernier prix

US$103.95

Capitalisation boursière

US$84.5b

7D

2.5%

1Y

41.8%

Mise à jour

22 Aug, 2024

Données

Finances de l'entreprise +

Colgate-Palmolive Company

NYSE:CL Rapport sur les actions

Capitalisation boursière : US$84.5b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

CL Aperçu des actions

Colgate-Palmolive Company, avec ses filiales, fabrique et vend des produits de consommation aux États-Unis et dans le monde entier.

CL analyse fondamentale
Score flocon de neige
Évaluation4/6
Croissance future2/6
Performances passées4/6
Santé financière4/6
Dividendes5/6

Community Narratives

Narratives bring a range of perspectives from our community.

US$100.30
FV
3.6% overvalued intrinsic discount
3.87%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
30 days agoauthor updated this narrative

Colgate-Palmolive Company Concurrents

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Colgate-Palmolive
Historique des cours de bourse
Prix actuel de l'actionUS$103.95
Plus haut sur 52 semainesUS$104.15
Plus bas sur 52 semainesUS$67.62
Bêta0.39
1Variation sur 1 mois7.66%
Variation sur 3 mois11.41%
Variation sur 1 an41.78%
3Variation sur 3 ans34.46%
Variation sur 5 ans40.09%
Évolution depuis l'introduction en bourse11,144.17%

Nouvelles et mises à jour récentes

Colgate-Palmolive: Stability Pillar Reached Its Fair Value

Aug 19

An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued

Aug 12
An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued

Colgate-Palmolive: Good Growth Prospects Ahead

Aug 06

Recent updates

Colgate-Palmolive: Stability Pillar Reached Its Fair Value

Aug 19

An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued

Aug 12
An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued

Colgate-Palmolive: Good Growth Prospects Ahead

Aug 06

Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)

Jul 11
Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)

Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings

Jul 10

Colgate-Palmolive: Gladly Holding, Yet Currently Not Buying An All Time Favorite

Jun 23

Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Jun 06
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital

May 21
Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital

Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report

Apr 30
Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report

Colgate-Palmolive: Loading Up Ahead Of Earnings

Apr 16

Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E

Apr 02
Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E

Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 18
Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year

Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?

Feb 14
Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?

Colgate-Palmolive: I'm Buying Before Interest Rates Decrease

Feb 14

Colgate-Palmolive: Brushing Up Profits In Q4 2023

Jan 30

Is Colgate-Palmolive (NYSE:CL) A Risky Investment?

Jan 19
Is Colgate-Palmolive (NYSE:CL) A Risky Investment?

Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult

Jan 01
Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult

Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)

Dec 20

Colgate-Palmolive Stock And Its Real Value

Nov 29

Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On

Nov 14

Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends

Nov 06
Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends

Colgate-Palmolive: Own This Dividend King At The Right Price

Oct 31

Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now

Oct 13

Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Oct 02
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Colgate-Palmolive: Dividend King With Limited Growth

Sep 27

An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued

Sep 11
An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued

Colgate-Palmolive: Improving Prospects And A Reasonable Valuation

Sep 09

Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World

Aug 16

Colgate And The Importance Of Sales Growth, Expectations Matter

Aug 09

Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business

Aug 03
Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business

Colgate-Palmolive: Challenging Growth Prospects

Jul 10

Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48

Jun 27
Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48

Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48

Jun 13
Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48

Colgate-Palmolive: The Reasons We Are Becoming More Cautious

Jun 05

Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly

Jun 05
Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly

Calculating The Intrinsic Value Of Colgate-Palmolive Company (NYSE:CL)

May 18
Calculating The Intrinsic Value Of Colgate-Palmolive Company (NYSE:CL)

Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Feb 23
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Calculating The Fair Value Of Colgate-Palmolive Company (NYSE:CL)

Feb 05
Calculating The Fair Value Of Colgate-Palmolive Company (NYSE:CL)

What to expect from Colgate-Palmolive's Q4 2022 Earnings

Jan 26

Rendement pour les actionnaires

CLUS Household ProductsUS Marché
7D2.5%1.2%3.1%
1Y41.8%10.6%24.9%

Rendement vs Industrie: CL a dépassé le secteur US Household Products qui a rapporté 10.5 % au cours de l'année écoulée.

Rendement vs marché: CL a dépassé le marché US qui a rapporté 25.6 % au cours de l'année écoulée.

Volatilité des prix

Is CL's price volatile compared to industry and market?
CL volatility
CL Average Weekly Movement2.3%
Household Products Industry Average Movement3.3%
Market Average Movement6.3%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market3.2%

Cours de l'action stable: CL n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: La volatilité hebdomadaire de CL ( 2% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

FondéeSalariésPDGSite web
180634,000Noel Wallacewww.colgatepalmolive.com

Colgate-Palmolive Company, avec ses filiales, fabrique et vend des produits de consommation aux États-Unis et dans le monde entier. Elle opère à travers deux segments : Oral, Personal and Home Care ; et Pet Nutrition. Le segment Oral, Personal and Home Care propose des dentifrices, des brosses à dents, des bains de bouche, des savons en barre et liquides, des gels douche, des shampooings, des après-shampooings, des déodorants et des anti-transpirants, des produits pour la santé de la peau, des détergents pour la vaisselle, des assouplissants, des nettoyants ménagers et d'autres articles connexes.

Colgate-Palmolive Company Résumé des fondamentaux

Comment les bénéfices et les revenus de Colgate-Palmolive se comparent-ils à sa capitalisation boursière ?
CL statistiques fondamentales
Capitalisation boursièreUS$84.54b
Bénéfices(TTM)US$2.84b
Recettes(TTM)US$19.99b

29.9x

Ratio P/E

4.2x

Ratio P/S

Le site CL est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
CL compte de résultat (TTM)
RecettesUS$19.99b
Coût des recettesUS$8.06b
Marge bruteUS$11.93b
Autres dépensesUS$9.09b
Les revenusUS$2.84b

Derniers bénéfices déclarés

Jun 30, 2024

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)3.48
Marge brute59.70%
Marge bénéficiaire nette14.21%
Ratio dettes/capitaux propres1,800.0%

Quelles ont été les performances à long terme de CL?

Voir les performances historiques et les comparaisons

Dividendes

1.9%

Rendement actuel des dividendes

56%

Ratio de distribution